Heart rate variability in beta-thalassemic mice.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  International Journal of Cardiology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 17113168
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A humanized BAC transgenic/knockout mouse model for HbE/beta-thalassemia.

  2006cited by this paper
• Early detection of cardiac dysfunction in thalassemic patients by radionuclide angiography and heart rate variability analysis

  2005cited by this paper
• Heart rate variability and ventricular late potentials in beta-thalassemia major.

  2004cited by this paper
• Generation of transgenic mice expressing human hemoglobin E.

  2004cited by this paper
• Flow cytometric measurement of reactive oxygen species production by normal and thalassaemic red blood cells

  2003cited by this paper
• MADIT-II and its implications.

  2003cited by this paper
• Baroreflex Sensitivity and Heart Rate Variability in the Identification of Patients at Risk for Life-Threatening Arrhythmias: Implications for Clinical Trials

  2001cited by this paper
• Autonomic cardiovascular control in conscious mice.

  2000cited by this paper
• Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart).

  1998cited by this paper
• Transgenic knockout mice exclusively expressing human hemoglobin S after transfer of a 240-kb betas-globin yeast artificial chromosome: A mouse model of sickle cell anemia.

  1998cited by this paper
• Blood pressure and heart rate in young thalassemia major patients.

  1998cited by this paper
• A mouse model for beta 0-thalassemia.

  1995cited by this paper
• Survival in medically treated patients with homozygous beta-thalassemia.

  1994cited by this paper
• Revised recommendations for the measurements of the serum iron in human blood

  1990cited by this paper
• Molecular basis of beta-thalassemia in Thailand: analysis of beta-thalassemia mutations using the polymerase chain reaction.

  1989cited by this paper

• N-Acetylcysteine enhances low-dose estrogen efficacy against ischemia-reperfusion injury in estrogen-deprived obese insulin-resistant rats

  2024cites this paper
• Nutraceutical Benefits of Green Tea in Beta-Thalassemia with Iron Overload

  2020cites this paper
• N-acetylcysteine with low-dose estrogen reduces cardiac ischemia-reperfusion injury.

  2019cites this paper
• Deferiprone and efonidipine mitigated iron-overload induced neurotoxicity in wild-type and thalassemic mice.

  2019cites this paper
• Astragalus polysaccharides meliorate cardiovascular dysfunction in iron-overloaded thalassemic mice

  2019cites this paper
• Combined iron chelator and T‐type calcium channel blocker exerts greater efficacy on cardioprotection than monotherapy in iron‐overload thalassemic mice

  2018cites this paper
• Diagnosis and treatment of cardiac iron overload in transfusion-dependent thalassemia patients

  2018cites this paper
• A combination of an iron chelator with an antioxidant exerts greater efficacy on cardioprotection than monotherapy in iron-overload thalassemic mice

  2018influential citation
• Cardiac complications in beta-thalassemia: From mice to men

  2017cites this paper
• Dual T‐type and L‐type calcium channel blocker exerts beneficial effects in attenuating cardiovascular dysfunction in iron‐overloaded thalassaemic mice

  2016cites this paper
• Estrogen and DPP4 inhibitor, but not metformin, exert cardioprotection via attenuating cardiac mitochondrial dysfunction in obese insulin-resistant and estrogen-deprived female rats

  2016cites this paper
• Effects of iron overload condition on liver toxicity and hepcidin/ferroportin expression in thalassemic mice.

  2016cites this paper
• Dipeptidyl peptidase‐4 inhibitor improves cardiac function by attenuating adverse cardiac remodelling in rats with chronic myocardial infarction

  2015cites this paper
• Heart Rate Variability as an Alternative Indicator for Identifying Cardiac Iron Status in Non-Transfusion Dependent Thalassemia Patients

  2015cites this paper
• Protective effects of garlic extract on cardiac function, heart rate variability, and cardiac mitochondria in obese insulin-resistant rats

  2014cites this paper
• Protocatechuic acid exerts a cardioprotective effect in type 1 diabetic rats.

  2014cites this paper
• Effects of vildagliptin versus sitagliptin, on cardiac function, heart rate variability and mitochondrial function in obese insulin‐resistant rats

  2013cites this paper
• Early detection of cardiac involvement in thalassemia: From bench to bedside perspective.

  2013cites this paper
• Cardiomyocyte ultrastructural damage in β‐thalassaemic mice

  2013cites this paper
• Cardioprotective effects of metformin and vildagliptin in adult rats with insulin resistance induced by a high-fat diet.

  2012cites this paper
• T‐type calcium channel blockade improves survival and cardiovascular function in thalassemic mice

  2012influential citation
• Mitochondrial calcium uniporter blocker prevents cardiac mitochondrial dysfunction induced by iron overload in thalassemic mice

  2012cites this paper
• Reversal of cardiac iron loading and dysfunction in thalassemic mice by curcuminoids.

  2011cites this paper
• T‐type calcium channel as a portal of iron uptake into cardiomyocytes of beta‐thalassemic mice

  2011cites this paper
• Effects of green tea on iron accumulation and oxidative stress in livers of iron-challenged thalassemic mice.

  2010cites this paper
• Effects of curcuminoid supplement on cardiac autonomic status in high-fat-induced obese rats.

  2009cites this paper